Optimal Length of Treatment Continuation With Olanzapine After Remission of Manic or Mixed Episode
Status:
Completed
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
This is a randomized, parallel, open-label study of patients who have responded to treatment
in the acute phase of their manic or mixed episode, with or without psychotic symptoms, with
olanzapine in mono or co-therapy, and who are in syndromic and symptomatic remission at the
time of enrollment into the study.